Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
- PMID: 31454670
- DOI: 10.1016/j.semcancer.2019.08.029
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
Abstract
Application of nanotechnologies to cancer therapy might increase solubility and/or bioavailability of bioactive compounds of natural or synthetic origin and offers other potential benefits in cancer therapy, including selective targeting. In the present review we aim to evaluate in vivo studies on the anticancer activity of nanoparticles (NPs) obtained from food-derived flavonoids. From a systematic search a total of 60 studies were identified. Most of the studies involved the flavanol epigallocatechin-3-O-gallate and the flavonol quercetin, in both delivery and co-delivery (with anti-cancer drugs) systems. Moreover, some studies investigated the effects of other flavonoids, such as anthocyanins aglycones anthocyanidins, flavanones, flavones and isoflavonoids. NPs inhibited tumor growth in both xenograft and chemical-induced animal models of cancerogenesis. Encapsulation improved bioavailability and/or reduced toxicity of both flavonoids and/or co-delivered drugs, such as doxorubicin, docetaxel, paclitaxel, honokiol and vincristine. Moreover, flavonoids have been successfully applied in molecular targeted nanosystems. Selectivity for cancer cells involves pH- and/or reactive oxygen species-mediated mechanisms. Furthermore, flavonoids are good candidates as drug delivery for anticancer drugs in green synthesis systems. In conclusion, although human studies are needed, NPs obtained from food-derived flavonoids have promising anticancer effects in vivo.
Keywords: Cancer; Epigallocatechin gallate; Flavonoids; Nanoparticle; Quercetin.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Nanoformulations of Nutraceuticals for Cancer Treatment.Crit Rev Eukaryot Gene Expr. 2019;29(5):449-460. doi: 10.1615/CritRevEukaryotGeneExpr.2019025957. Crit Rev Eukaryot Gene Expr. 2019. PMID: 32422001 Review.
-
Novel Phospholipid-Based Labrasol Nanomicelles Loaded Flavonoids for Oral Delivery with Enhanced Penetration and Anti-Brain Tumor Efficiency.Curr Drug Deliv. 2020;17(3):229-245. doi: 10.2174/1567201817666200210120950. Curr Drug Deliv. 2020. PMID: 32039682
-
Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.Semin Cancer Biol. 2021 Feb;69:200-211. doi: 10.1016/j.semcancer.2019.07.023. Epub 2019 Jul 30. Semin Cancer Biol. 2021. PMID: 31374244 Review.
-
pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.Acta Biomater. 2017 Aug;58:349-364. doi: 10.1016/j.actbio.2017.04.029. Epub 2017 Apr 26. Acta Biomater. 2017. PMID: 28455219
-
Delivering flavonoids into solid tumors using nanotechnologies.Expert Opin Drug Deliv. 2013 Oct;10(10):1411-28. doi: 10.1517/17425247.2013.807795. Epub 2013 Jul 18. Expert Opin Drug Deliv. 2013. PMID: 23862581 Review.
Cited by
-
Nano-Drug Delivery Systems Based on Natural Products.Int J Nanomedicine. 2024 Jan 18;19:541-569. doi: 10.2147/IJN.S443692. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260243 Free PMC article. Review.
-
Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway.Int J Mol Sci. 2023 May 25;24(11):9236. doi: 10.3390/ijms24119236. Int J Mol Sci. 2023. PMID: 37298188 Free PMC article. Review.
-
The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.Front Pharmacol. 2023 May 24;14:1201085. doi: 10.3389/fphar.2023.1201085. eCollection 2023. Front Pharmacol. 2023. PMID: 37292151 Free PMC article. Review.
-
Functional characterization of nine critical genes encoding rate-limiting enzymes in the flavonoid biosynthesis of the medicinal herb Grona styracifolia.BMC Plant Biol. 2023 Jun 3;23(1):299. doi: 10.1186/s12870-023-04290-z. BMC Plant Biol. 2023. PMID: 37268882 Free PMC article.
-
Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications.Pharmaceuticals (Basel). 2023 May 12;16(5):736. doi: 10.3390/ph16050736. Pharmaceuticals (Basel). 2023. PMID: 37242519 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases